C-Bridge Capital

C-Bridge Capital is a venture capital firm in New York that focuses on healthcare investments. Founded in New York, United States, it invests in early stage ventures. Its portfolio companies include GrayBugGrayBug, I-Mab Biopharma, Nuance Biotech, CMLabs, CMAB BioPharm, Anrei Medical, and Clarus Therapeutics. As of February 2020, C-Bridge Capital has made eight investments. Their most recent investment was on Aug 20, 2019, when GrayBug raised $80M. C-Bridge Capital has had one exit, which was I-Mab Biopharma.

C-Bridge Capital is a venture capital firm in New York that focuses on healthcare investments. Founded in New York, United StatesUnited States, it invests in early stage ventures. Its portfolio companies include GrayBug, I-Mab Biopharma, Nuance Biotech, CMLabs, CMAB BioPharm, Anrei Medical, and Clarus Therapeutics. As of February 2020, C-Bridge Capital has made eight investments. Their most recent investment was on Aug 20, 2019, when GrayBug raised $80M. C-Bridge Capital has had one exit, which was I-Mab Biopharma.

C-Bridge Capital is a venture capital firm in New York that focuses on healthcare investments. Founded in New York, United States, it invests in early stage ventures. Its portfolio companies include GrayBug, I-Mab Biopharma, Nuance Biotech, CMLabs, CMAB BioPharm, Anrei Medical, and Clarus Therapeutics. As of February 2020, C-Bridge Capital has made eight investments. Their most recent investment was on Aug 20, 2019, when GrayBug raised $80M. C-Bridge Capital has had one exit, which was I-Mab Biopharma.